These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10958113)

  • 1. Cannabinoid receptors and reward in the rat: a conditioned place preference study.
    Cheer JF; Kendall DA; Marsden CA
    Psychopharmacology (Berl); 2000 Jul; 151(1):25-30. PubMed ID: 10958113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.
    Sañudo-Peña MC; Tsou K; Delay ER; Hohman AG; Force M; Walker JM
    Neurosci Lett; 1997 Feb; 223(2):125-8. PubMed ID: 9089689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea.
    Parker LA; Mechoulam R; Schlievert C; Abbott L; Fudge ML; Burton P
    Psychopharmacology (Berl); 2003 Mar; 166(2):156-62. PubMed ID: 12528012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.
    Chaperon F; Soubrié P; Puech AJ; Thiébot MH
    Psychopharmacology (Berl); 1998 Feb; 135(4):324-32. PubMed ID: 9539255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
    Braida D; Pozzi M; Cavallini R; Sala M
    Neuroscience; 2001; 104(4):923-6. PubMed ID: 11457579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.
    Ramiro-Fuentes S; Ortiz O; Moratalla R; Fernandez-Espejo E
    Neuroscience; 2010 May; 167(2):205-15. PubMed ID: 20167255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats.
    Parker LA; Mechoulam R
    Integr Physiol Behav Sci; 2003; 38(2):133-45. PubMed ID: 14527182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed.
    Ralevic V; Kendall DA
    Eur J Pharmacol; 2001 Apr; 418(1-2):117-25. PubMed ID: 11334873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid-Elicited Conditioned Place Preference in a Modified Behavioral Paradigm.
    Liu T; Zheng Q; Qian Z; Wang H; Liu Z; Ren W; Zhang X; Han J
    Biol Pharm Bull; 2016 May; 39(5):747-53. PubMed ID: 26935020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study.
    Cheer JF; Marsden CA; Kendall DA; Mason R
    Neuroscience; 2000; 99(4):661-7. PubMed ID: 10974429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones.
    Millns PJ; Chapman V; Kendall DA
    Br J Pharmacol; 2001 Mar; 132(5):969-71. PubMed ID: 11226126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE; Beninger RJ
    Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.
    Valjent E; Maldonado R
    Psychopharmacology (Berl); 2000 Jan; 147(4):436-8. PubMed ID: 10672638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cannabinoid mechanism in relapse to cocaine seeking.
    De Vries TJ; Shaham Y; Homberg JR; Crombag H; Schuurman K; Dieben J; Vanderschuren LJ; Schoffelmeer AN
    Nat Med; 2001 Oct; 7(10):1151-4. PubMed ID: 11590440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
    Welch SP; Huffman JW; Lowe J
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
    Carta G; Nava F; Gessa GL
    Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
    Darmani NA
    Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
    Ghozland S; Matthes HW; Simonin F; Filliol D; Kieffer BL; Maldonado R
    J Neurosci; 2002 Feb; 22(3):1146-54. PubMed ID: 11826143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of cannabinoid dependence in animals.
    Maldonado R
    Pharmacol Ther; 2002 Aug; 95(2):153-64. PubMed ID: 12182962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.